Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant
- 1 March 2004
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 10 (3) , 255-257
- https://doi.org/10.1111/j.1198-743x.2004.00837.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Refractory Aspergillus pneumonia in patients with acute leukemiaCancer, 2003
- Progressive Cutaneous Hyalohyphomycosis Due toPaecilomyces lilacinus:Rapid Response to Treatment with Caspofungin and ItraconazoleClinical Infectious Diseases, 2002
- Caspofungin in Combination with Itraconazole for the Treatment of Invasive Aspergillosis in HumansClinical Infectious Diseases, 2002
- Invasive Aspergillosis in Allogeneic Stem Cell Transplant Recipients: Increasing Antigenemia Is Associated with Progressive DiseaseClinical Infectious Diseases, 2002
- Combination therapy with caspofungin and amphotericin B lipid complexAmerican Journal of Health-System Pharmacy, 2002
- Trends in the Epidemiology of Opportunistic Fungal Infections: Predisposing Factors and the Impact of Antimicrobial Use PracticesClinical Infectious Diseases, 2001
- Practice Guidelines for Diseases Caused by AspergillusClinical Infectious Diseases, 2000